近日, Journal of Diabetes 杂志联合 主编Zachary Bloomgarden教授发表述评,标题为“Diabetes and COVID-19”。 目前,中国和世界面临着前所未有的高传染性病毒疾病的巨大挑战。每年,数百万人(占世界人口的5%-15%)感染流感,造成30万至60万人因呼吸系统疾病额外死亡。仅在中国,最近的估计显示每年与流感有关的死亡率超...
Quality of care in patients with type 1 diabetes during the COVID-19 pandemic: a cohort study from Southern Brazil Optimal glycemic control is the main goal for patients with diabetes. The results of type 1 diabetes patients’ neglected demands during the pandemic can determine a long-term ne...
Some patients were driven by curiosity, while others realised they had not seen a general practitioner for a long time and perceived it as an opportunity to learn more about their health. Other motivators were the fear of the detrimental effect of the targeted diseases on their health, having...
I enjoyed attending the conference and was such a pleasure to see other participants from other countries. Your team has been very organized. I hope the COVID-19 situation will finish soon and we can have face to face conferences. I like to be informed about your future conferences. ...
Diabetes and COVIDdoi:10.1111/1753-0407.13027Zachary T. BloomgardenDepartment of Medicine, Division of Endocrinology, Diabetes, and Bone Disease Icahn School of Medicine at Mount Sinai New York New YorkJohn Wiley & Sons, LtdJournal of Diabetes...
Dexamethasone use significantly improved the final outcome based on net reclassification improvement (NRI) and integrated discrimination improvement (IDI) (p < 0.05). In this single-center study, T2DM was very common among hospitalized Covid-19 patients. Patients > 50 years, those with congestive ...
The drug metformin cut long COVID risk by 41 percent in both people who were overweight and those with obesity. But treatments remain elusive
New type 2 diabetes more likely in youth after COVID-19 vs. other respiratory diseases Children and adolescents diagnosed with COVID-19 were more likely to develop new-onset type 2 diabetes than those who had other respiratory infections, accord...
Children with diabetes do not seem to be at higher risk of getting COVID-19 infection compared to those with no diabetes. However, the infection may make the blood glucose difficult to manage and may impact the ability to take in carbohydrates. More importantly, access to care may be delayed...
COVID-19 and diabetes mellitus: from pathophysiology to clinical management The pathophysiology of coronavirus disease 19 (COVID-19) and diabetes mellitus are interlinked, and diabetes mellitus is associated with severe COVID-19 outcomes. This Review highlights new advances in diabetes mellitus and CO...